Clinical and genomic predictors of adverse events in newly diagnosed glioblastoma

Post time 2024-1-26 04:00:13

journal：Clinical Cancer Research

Authors：Mary Jane Lim-Fat; J. Bryan. Iorgulescu; Rifaquat Rahman; Varun Bhave; Alona Muzikansky; Eleanor Woodward; Sydney Whorral; Marie Allen; Mehdi Touat; Xiaomei Li; Gongwen Xu; Jay Patel; Elizabeth R. Gerstner; Jayashree Kalpathy-Cramer; Gilbert Youssef; Ugonma Chukwueke; J. Ricardo. McFaline-Figueroa; Lakshmi Nayak; Eudocia Q. Lee; David A. Reardon; Rameen Beroukhim; Raymond Y. Huang; Wenya Linda Bi; Keith L. Ligon; Patrick Y. Wen

Published date：--

DOI：10.1158/1078-0432.ccr-23-3018

PDF link：https://aacrjournals.org/clincan ... 253/ccr-23-3018.pdf

Article link：http://dx.doi.org/10.1158/1078-0432.ccr-23-3018

Article Source：American Association for Cancer Research (AACR)。

Remark：

Post time 2024-1-26 04:00:14

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AACR] Clinical and genomic predictors of adverse events in newly diagnosed glioblastoma

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AACR] Clinical and genomic predictors of adverse events in newly diagnosed glioblastoma Copy